Advanced Cell Technology Company Description
No need to choose between embryonic and adult stem cells -- Advanced Cell Technology (ACT) works with both to develop possible means to regenerate human tissue. The company has an assortment of patented means of creating new human stem cells from either embryos or adult stem cells. It hopes to find applications of its regenerative cell methods to address acute, chronic, and degenerative diseases, as well as regenerative conditions (e.g., trauma, infarction, burns). ACT is conducting research at both the pre-clinical and clinical trial levels. Its research with adult stem cells is focused on restoring cardiac function in patients with advanced heart disease.
View the Comprehensive Company Description for Advanced Cell Technology
The Company Description provides a historical perspective of Advanced Cell Technology's organization from inception to current status.
Produced by Hoover's in-house editorial team, the Company Description tracks ownership transitions, company progress via mergers and acquisitions, major growth milestones, and strategic initiatives, to provide a holistic view of Advanced Cell Technology's evolution in the marketplace.
